Pfizer, Moderna begin legal battle over Covid-19 vaccine patents in UK

By NS Healthcare Staff Writer 24 Apr 2024

The competing lawsuits over Covid-19 vaccines are a part of the ongoing litigation worldwide, centred around mRNA technology, where Pfizer, BioNTech and Moderna are involved in legal battles in Germany, the Netherlands, Belgium and the US

Pharmaceuticals

Patient Care

Nutraceuticals

Pfizer, Moderna begin legal battle over Covid-19 vaccine patents in UK

Incyte to acquire Escient Pharmaceuticals for over $750m

AIRS Medical Accelerates Global Expansion with MRI AI....

Immunovia announces positive results from the model-development study....

Pfizer’s Emblaveo gets EC approval for treatment of....

Pharmaceuticals

Ipsen, Skyhawk enter $1.8bn RNA-targeting research collaboration
23 Apr 24

Ochre Bio, Boehringer Ingelheim to join forces to develop RNA therapeutics for CLDs
23 Apr 24

ImmunityBio’s Anktiva gains FDA approval for BCG-unresponsive NMIBC
23 Apr 24

Patient Care

Zydus launches Mirabegron Extended-Release Tablets in the US
23 Apr 24

Roche’s Alecensa wins FDA approval for ALK-positive NSCLC
22 Apr 24

FDA approves SC delivery of Takeda’s Entyvio for Crohn’s disease
19 Apr 24

Nutraceuticals

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects
05 Apr 24

Arla Foods announces plans to become major UK exporter of mozzarella
05 Apr 24

Davos Life Science achieves FSSC 22000 certification, demonstrating unwavering commitment to food safety excellence
05 Apr 24

NS Healthcare is using cookies

Ipsen, Skyhawk enter $1.8bn RNA-targeting research collaboration23 Apr 24

Ochre Bio, Boehringer Ingelheim to join forces to develop RNA therapeutics for CLDs23 Apr 24

ImmunityBio’s Anktiva gains FDA approval for BCG-unresponsive NMIBC23 Apr 24

Zydus launches Mirabegron Extended-Release Tablets in the US 23 Apr 24

Roche’s Alecensa wins FDA approval for ALK-positive NSCLC 22 Apr 24

FDA approves SC delivery of Takeda’s Entyvio for Crohn’s disease 19 Apr 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects05 Apr 24

Arla Foods announces plans to become major UK exporter of mozzarella05 Apr 24

Davos Life Science achieves FSSC 22000 certification, demonstrating unwavering commitment to food safety excellence05 Apr 24

OUR TITLES

Covid-19 spurred on the self-testing revolution23 Apr 24

Oxford Properties starts work on Ionis....06 Dec 23

Healthpeak to merge with Physicians Realty....31 Oct 23

PepsiCo Beverage’s Sacramento-Based Electric Fleet Is....29 Sep 23

Lilly acquires new injectable medicine manufacturing....23 Apr 24

Genmab to acquire ADC developer ProfoundBio....03 Apr 24

Novo Nordisk to buy cardiovascular drugmaker....26 Mar 24

Nuvation Bio to acquire oncology firm....26 Mar 24

Neomorph, Novo Nordisk enter $1.46bn partnership....27 Feb 24

AbbVie, Tentarix partner to develop oncology....23 Feb 24

General Dynamics unit wins $2.5bn contract....14 Nov 23

SGC, HitGen collaborate on DEL technology....29 Sep 23

Ipsen, Skyhawk enter $1.8bn RNA-targeting research collaboration
23 Apr 24

Ochre Bio, Boehringer Ingelheim to join forces to develop RNA therapeutics for CLDs
23 Apr 24

ImmunityBio’s Anktiva gains FDA approval for BCG-unresponsive NMIBC
23 Apr 24

Zydus launches Mirabegron Extended-Release Tablets in the US
23 Apr 24

Roche’s Alecensa wins FDA approval for ALK-positive NSCLC
22 Apr 24

FDA approves SC delivery of Takeda’s Entyvio for Crohn’s disease
19 Apr 24

Squalene Shows Promise in Reducing Mortality and Re-hospitalization Among COVID-19 Subjects
05 Apr 24

Arla Foods announces plans to become major UK exporter of mozzarella
05 Apr 24

Davos Life Science achieves FSSC 22000 certification, demonstrating unwavering commitment to food safety excellence
05 Apr 24

Covid-19 spurred on the self-testing revolution
23 Apr 24

Oxford Properties starts work on Ionis....
06 Dec 23

Healthpeak to merge with Physicians Realty....
31 Oct 23

PepsiCo Beverage’s Sacramento-Based Electric Fleet Is....
29 Sep 23

Lilly acquires new injectable medicine manufacturing....
23 Apr 24

Genmab to acquire ADC developer ProfoundBio....
03 Apr 24

Novo Nordisk to buy cardiovascular drugmaker....
26 Mar 24

Nuvation Bio to acquire oncology firm....
26 Mar 24

Neomorph, Novo Nordisk enter $1.46bn partnership....
27 Feb 24

AbbVie, Tentarix partner to develop oncology....
23 Feb 24

General Dynamics unit wins $2.5bn contract....
14 Nov 23

SGC, HitGen collaborate on DEL technology....
29 Sep 23